HB1011

N/A

Report date: 2025/12/23 17:47:51

Base Information

Drug NameHB1011
Drug Alias NameHB1011HB-1011
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiogenic potential stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesHieraBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesHieraBio Inc
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A